Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) perioperative treatment regimen has been recommended by the European Medicines Agency’s human medicines committee for adults with ...
Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s ...
Pembrolizumab shows clinical promise as a treatment for mycosis fungoides and Sézary syndrome, achieving a response in nearly ...
6h
Zacks Investment Research on MSNBiotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & MoreIt was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of ...
Opinion
5hOpinion
Zacks Investment Research on MSNTop Research Reports for Exxon Mobil, Bristol-Myers Squibb & ChubbThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), ...
Despite being the most abundant element in the universe, making cheap, clean hydrogen here on Earth has been a surprisingly ...
University of Colorado mechanical engineering laboratory is on track to win the race to provide low-cost batteries with ...
16h
GlobalData on MSNLGES to acquire GM’s stake in battery plant for KRW3trnEV battery manufacturer LG Energy Solution Ltd confirmed that it has agreed to acquire General Motors’ stake in one of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results